B
B

Beazley

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

JPM stays upbeat on European insurance into 2024

BUZZ-JPM stays upbeat on European insurance into 2024 ** J.P.Morgan remains positive on European insurance in 2024, citing peak yields, no threat from peak pricing, earnings growth, and benign credit risk ** The broker says peak yields are likely to be a net positive, especially for high capital return stocks such as UK life and Benelux names, addi
A
A
A
A
B
H
J
L
L
P
S
S
A
P
S
Z

Rising war risks prompt property insurers to rethink cover

Rising war risks prompt property insurers to rethink cover By Carolyn Cohn and Noor Zainab Hussain LONDON, Dec 6 (Reuters) - Insurers grappling with the rising risk of physical attacks on businesses due to war or civil disorder are reconsidering the breadth and scope of such cover in potential conflict hot spots. Political violence cover, which businesses can take out to insure against physical damage caused by war, terror attacks, strikes or riots, can be bought as a standalone policy alongside
B

AstraZeneca, Barclays, BASF SE

EUROPE RESEARCH ROUNDUP-AstraZeneca, Barclays, BASF SE Nov 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Barclays, and BASF SE on Monday. HIGHLIGHTS * AstraZeneca AZN.L : Jefferies cuts target price to 12500p from 13000p * Barclays BARC.L : Jefferies cuts target price to 230p from 300p * BASF SE BASFn.DE : Morgan Stanley cuts to underweight from equalweight * Elior ELIOR.PA : Deutsche Bank raises to buy from hold
A
A
A
A
A
A
B
B
B
B
B
B
B
B
C
D
D
E
E
E
F
G
H
I
A
H
A
D
I

Ashtead Group, Bayer, Diploma Plc

EUROPE RESEARCH ROUNDUP- Ashtead Group, Bayer, Diploma Plc Nov 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Group, Bayer AG, and Diploma Plc, on Tuesday. HIGHLIGHTS * Ashtead Group AHT.L : Barclays cuts target price to 6000p from 6300p * Bayer AG BAYGn.DE : Barclays cuts to equal-weight from overweight * Diploma Plc DPLM.L : Peel Hunt raises target price to 3,600p from 3,450p * Intermediate Capital Group Plc ICP.L : J
A
A
B
B
B
C
C
D
D
E
E
H
H
I
M
N
R
S
S
V
V
A
B
B
B
D
I
J

Lloyd's of London SPAC venture scrapped due to volatile markets

UPDATE 1-Lloyd's of London SPAC venture scrapped due to volatile markets Writes through with more detail, LIU comment By Huw Jones LONDON, Nov 13 (Reuters) - Financials Acquisition Corp FINSF.L said on Monday it would enter liquidation as it scraps a planned merger with its newly formed insurance venture, citing "insufficient" cash commitments due to volatile capital markets.
B
H
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.